# Aspirin may take a back row seat for non-ST-segment elevation acute coronary syndrome after percutaneous coronary intervention

**Authors:** Patricia O Guimarães, Caio A M Tavares, Marcelo Franken, Pedro A Lemos

PMC · DOI: 10.1093/ehjcvp/pvaf090 · European Heart Journal. Cardiovascular Pharmacotherapy · 2026-01-29

## Full-text entities

- **Diseases:** acute coronary syndrome (MESH:D054058)
- **Chemicals:** Aspirin (MESH:D001241)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946960/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946960/full.md

---
Source: https://tomesphere.com/paper/PMC12946960